SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2v9t'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ETB_2_T442129_1
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 6 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.83A 1etb2-2v9tB:
undetectable
1etb2-2v9tB:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SN5_C_T3C601_2
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 8 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.96A 1sn5C-2v9tB:
undetectable
1sn5C-2v9tB:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TW4_A_CHDA131_0
(FATTY ACID-BINDING
PROTEIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
5 / 11 LEU B 374
ASN B 406
ILE B 384
LEU B 363
PHE B 392
None
1.33A 1tw4A-2v9tB:
undetectable
1tw4A-2v9tB:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TYR_B_9CRB130_1
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 7 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.87A 1tyrB-2v9tB:
undetectable
1tyrB-2v9tB:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YAJ_D_BEZD2385_0
(CES1 PROTEIN)
2v9t ROUNDABOUT HOMOLOG 1
SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens;
Homo
sapiens)
4 / 5 SER A 117
LEU A 122
LEU A 127
LEU B 400
None
1.13A 1yajD-2v9tA:
undetectable
1yajD-2v9tA:
12.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HRC_A_CHDA703_0
(FERROCHELATASE)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 4 LEU B 291
PRO B 295
LEU B 307
ARG B 287
None
1.24A 2hrcA-2v9tB:
undetectable
2hrcA-2v9tB:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OAX_A_SNLA1001_1
(MINERALOCORTICOID
RECEPTOR)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
5 / 12 LEU B 387
LEU B 367
LEU B 353
LEU B 398
THR B 415
None
1.10A 2oaxA-2v9tB:
undetectable
2oaxA-2v9tB:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNJ_A_CHDA501_0
(FERROCHELATASE,
MITOCHONDRIAL)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
5 / 12 LEU B 326
LEU B 350
LEU B 371
ILE B 305
LEU B 363
None
1.01A 2pnjA-2v9tB:
undetectable
2pnjA-2v9tB:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNJ_A_CHDA501_0
(FERROCHELATASE,
MITOCHONDRIAL)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
5 / 12 LEU B 350
LEU B 374
LEU B 395
ILE B 329
LEU B 387
None
1.04A 2pnjA-2v9tB:
undetectable
2pnjA-2v9tB:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PRG_A_BRLA1_2
(PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
GAMMA)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
3 / 3 ILE B 329
ILE B 315
LEU B 398
None
0.54A 2prgA-2v9tB:
undetectable
2prgA-2v9tB:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2REZ_A_ACTA156_0
(MULTIFUNCTIONAL
CYCLASE-DEHYDRATASE-
3-O-METHYL
TRANSFERASE TCMN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 7 THR B 415
TRP B 440
MET B 425
LEU B 427
None
1.43A 2rezA-2v9tB:
0.0
2rezA-2v9tB:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VCT_A_ASDA1223_1
(GLUTATHIONE
S-TRANSFERASE A2)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 8 ILE B 384
LEU B 355
LEU B 353
PHE B 392
None
0.87A 2vctA-2v9tB:
undetectable
2vctA-2v9tB:
24.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AIA_A_SAMA206_0
(UPF0217 PROTEIN
MJ1640)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 6 LEU B 355
GLY B 357
LEU B 353
SER B 352
None
0.77A 3aiaA-2v9tB:
undetectable
3aiaA-2v9tB:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HCO_B_CHDB1_0
(FERROCHELATASE,
MITOCHONDRIAL)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 4 LEU B 291
PRO B 295
LEU B 307
ARG B 287
None
1.32A 3hcoB-2v9tB:
undetectable
3hcoB-2v9tB:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C9K_A_CAMA424_0
(CYTOCHROME P450)
2v9t ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
5 / 9 THR A 110
THR A  86
LEU A 121
LEU A 122
GLY A 125
None
1.48A 4c9kA-2v9tA:
undetectable
4c9kA-2v9tA:
14.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D7B_B_TCWB1126_1
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 7 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.97A 4d7bA-2v9tB:
undetectable
4d7bA-2v9tB:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IIZ_B_LURB201_1
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 8 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.96A 4iizB-2v9tB:
undetectable
4iizB-2v9tB:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IK6_B_LURB201_1
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 8 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.95A 4ik6B-2v9tB:
undetectable
4ik6B-2v9tB:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KLA_A_CHDA502_0
(FERROCHELATASE,
MITOCHONDRIAL)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 8 LEU B 326
LEU B 350
LEU B 371
ILE B 305
None
0.87A 4klaA-2v9tB:
undetectable
4klaA-2v9tB:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N48_B_SAMB601_1
(CAP-SPECIFIC MRNA
(NUCLEOSIDE-2'-O-)-M
ETHYLTRANSFERASE 1)
2v9t ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
4 / 5 PRO A  84
GLY A  82
ASP A  76
ASP A 141
None
1.07A 4n48B-2v9tA:
undetectable
4n48B-2v9tA:
15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PWJ_A_30ZA201_1
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 6 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.89A 4pwjA-2v9tB:
undetectable
4pwjA-2v9tB:
19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PWJ_B_30ZB201_1
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 7 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.84A 4pwjB-2v9tB:
undetectable
4pwjB-2v9tB:
19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZE2_A_1YNA602_2
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
2v9t ROUNDABOUT HOMOLOG 1
SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 5 ALA A 161
TYR A 145
HIS B 426
PHE A 129
None
1.04A 4ze2A-2v9tA:
undetectable
4ze2A-2v9tA:
12.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZOW_A_CLMA500_0
(MULTIDRUG
TRANSPORTER MDFA)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
6 / 11 LEU B 441
LEU B 379
LEU B 398
LEU B 419
ILE B 422
LEU B 377
None
1.23A 4zowA-2v9tB:
undetectable
4zowA-2v9tB:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BOJ_B_4TXB201_1
(TRANSTHYRETIN)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 7 LEU B 363
THR B 415
ALA B 391
LEU B 367
None
0.83A 5bojB-2v9tB:
undetectable
5bojB-2v9tB:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KVA_B_SAMB301_0
(CAFFEOYL-COA
O-METHYLTRANSFERASE)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
5 / 12 MET B 425
THR B 424
GLY B 454
ILE B 468
ALA B 428
None
1.19A 5kvaB-2v9tB:
undetectable
5kvaB-2v9tB:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6C06_D_FI8D1404_0
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA
DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA')
2v9t ROUNDABOUT HOMOLOG 1
SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens;
Homo
sapiens)
4 / 8 ILE A  70
ARG B 287
LYS B 289
SER B 280
None
0.99A 6c06C-2v9tA:
undetectable
6c06C-2v9tA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DWN_A_AQ4A602_0
(CYTOCHROME P450 1A1)
2v9t ROUNDABOUT HOMOLOG 1
SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens;
Homo
sapiens)
5 / 12 SER A  75
ASN B 334
ASN B 358
LEU B 331
GLY B 288
None
1.30A 6dwnA-2v9tA:
undetectable
6dwnA-2v9tA:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F88_A_STRA502_1
(CYTOCHROME P450
CYP260A1)
2v9t SLIT HOMOLOG 2
PROTEIN N-PRODUCT

(Homo
sapiens)
4 / 6 PHE B 344
LEU B 367
ALA B 343
ASN B 334
None
0.99A 6f88A-2v9tB:
undetectable
6f88A-2v9tB:
15.91